← back to search
Ping Wei
Nanjing University of Chinese Medicine
· CN
Area of research
Cognitive Neuroscience · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Fenofibrate, Statin, Triglyceride, and Hydroxymethylglutaryl-CoA Reductase Inhibitors.
h-index
—
citations
20
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Efficacy and safety of fenofibrate as an add-on in patients with elevated triglyceride despite receiving statin treatment
International Journal of Cardiology
2016
cited by
20
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Hong Chen
· Harbin Medical University
1
papers (2016–2016)
Ling Lin
· Nanchang University
1
papers (2016–2016)
Guang Wang
· Nanjing Agricultural University
1
papers (2016–2016)
Guosheng Fu
· The First Affiliated Hospital, Sun Yat-sen University
1
papers (2016–2016)
Li Yan
· Air Force Medical University
1
papers (2016–2016)
Hui Gong
· Central South University
1
papers (2016–2016)
Xuebo Liu
· Fudan University
1
papers (2016–2016)
—
·
1
papers (2016–2016)
Xingbo Cheng
· Harbin Medical University
1
papers (2016–2016)
—
·
1
papers (2016–2016)
Xiaodong Li
· Henan University
1
papers (2016–2016)
Yugang Dong
· Sun Yat-sen University
1
papers (2016–2016)
—
·
1
papers (2016–2016)
Hongman Huang
· University of Shanghai for Science and Technology
1
papers (2016–2016)
Shiwei Cui
· Nantong University
1
papers (2016–2016)
—
·
1
papers (2016–2016)
—
·
1
papers (2016–2016)
Dao Wen Wang
· Tongji Hospital
1
papers (2016–2016)
Yuehui Yin
· Dalian Medical University
1
papers (2016–2016)
Zhaoping Li
· Jiangnan University
1
papers (2016–2016)